Taiwan · Delayed Price · Currency is TWD 3D Global Biotech Statistics
Total Valuation
TPEX:6808 has a market cap or net worth of TWD 2.85 billion. The enterprise value is 2.40 billion.
| Market Cap | 2.85B |
| Enterprise Value | 2.40B |
Important Dates
The next estimated earnings date is Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | Jul 16, 2026 |
Share Statistics
TPEX:6808 has 76.98 million shares outstanding. The number of shares has increased by 0.57% in one year.
| Current Share Class | 76.98M |
| Shares Outstanding | 76.98M |
| Shares Change (YoY) | +0.57% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | 27.88% |
| Owned by Institutions (%) | 3.25% |
| Float | 48.94M |
Valuation Ratios
The trailing PE ratio is 205.84.
| PE Ratio | 205.84 |
| Forward PE | n/a |
| PS Ratio | 17.89 |
| PB Ratio | 3.89 |
| P/TBV Ratio | 4.27 |
| P/FCF Ratio | 53.72 |
| P/OCF Ratio | 43.20 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 127.28, with an EV/FCF ratio of 45.20.
| EV / Earnings | 168.81 |
| EV / Sales | 15.05 |
| EV / EBITDA | 127.28 |
| EV / EBIT | n/a |
| EV / FCF | 45.20 |
Financial Position
The company has a current ratio of 11.61, with a Debt / Equity ratio of 0.06.
| Current Ratio | 11.61 |
| Quick Ratio | 10.83 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 2.40 |
| Debt / FCF | 0.85 |
| Interest Coverage | -6.05 |
Financial Efficiency
Return on equity (ROE) is 1.73% and return on invested capital (ROIC) is -1.55%.
| Return on Equity (ROE) | 1.73% |
| Return on Assets (ROA) | -0.41% |
| Return on Invested Capital (ROIC) | -1.55% |
| Return on Capital Employed (ROCE) | -0.80% |
| Weighted Average Cost of Capital (WACC) | 4.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 43 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.90 |
Taxes
In the past 12 months, TPEX:6808 has paid 5.89 million in taxes.
| Income Tax | 5.89M |
| Effective Tax Rate | 29.31% |
Stock Price Statistics
The stock price has decreased by -15.82% in the last 52 weeks. The beta is 0.14, so TPEX:6808's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -15.82% |
| 50-Day Moving Average | 34.05 |
| 200-Day Moving Average | 38.74 |
| Relative Strength Index (RSI) | 49.84 |
| Average Volume (20 Days) | 274,670 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6808 had revenue of TWD 159.19 million and earned 14.20 million in profits. Earnings per share was 0.18.
| Revenue | 159.19M |
| Gross Profit | 105.86M |
| Operating Income | -6.15M |
| Pretax Income | 20.08M |
| Net Income | 14.20M |
| EBITDA | 7.99M |
| EBIT | -6.15M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 497.11 million in cash and 45.16 million in debt, with a net cash position of 451.95 million or 5.87 per share.
| Cash & Cash Equivalents | 497.11M |
| Total Debt | 45.16M |
| Net Cash | 451.95M |
| Net Cash Per Share | 5.87 |
| Equity (Book Value) | 732.73M |
| Book Value Per Share | 9.26 |
| Working Capital | 503.57M |
Cash Flow
In the last 12 months, operating cash flow was 65.93 million and capital expenditures -12.91 million, giving a free cash flow of 53.02 million.
| Operating Cash Flow | 65.93M |
| Capital Expenditures | -12.91M |
| Depreciation & Amortization | 14.14M |
| Net Borrowing | -7.68M |
| Free Cash Flow | 53.02M |
| FCF Per Share | 0.69 |
Margins
Gross margin is 66.50%, with operating and profit margins of -3.86% and 8.92%.
| Gross Margin | 66.50% |
| Operating Margin | -3.86% |
| Pretax Margin | 12.61% |
| Profit Margin | 8.92% |
| EBITDA Margin | 5.02% |
| EBIT Margin | -3.86% |
| FCF Margin | 33.31% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.27%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 290.69% |
| Buyback Yield | -0.57% |
| Shareholder Yield | -0.30% |
| Earnings Yield | 0.50% |
| FCF Yield | 1.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |